Targeted Drug Formulation Delivery

Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.

17,454 US filings from 5,808 companies since 2023 · 2023: 5,152 · 2024: 5,171 · 2025: 5,007 · 2026 YTD: 2,124

Pharmaceutical PreparationsDrug Delivery Devices

Top companies

Ranked by filings in this theme since 2023. 2026 is partial.

#	Company	Since 2023	2023	2024	2025	2026 YTD	YoY
1	The Regents of the University of California	138	48	31	47	12	+51.6%
2	MASSACHUSETTS INSTITUTE OF TECHNOLOGY	107	41	26	32	8	+23.1%
3	Regeneron Pharmaceuticals, Inc.	104	28	31	30	15	-3.2%
4	AMGEN INC.	92	28	21	33	10	+57.1%
5	ELI LILLY AND COMPANY	88	25	29	26	8	-10.3%
6	Novartis AG	81	23	25	26	7	+4.0%
7	The Johns Hopkins University	81	31	21	19	10	-9.5%
8	Board of Regents, The University of Texas System	76	25	22	23	6	+4.5%
9	Veradermics, Incorporated	74	·	·	29	45	—
10	NOVO NORDISK A/S	72	30	17	15	10	-11.8%
11	Boston Scientific Scimed, Inc.	69	13	19	24	13	+26.3%
12	LTS Lohmann Therapie-Systeme AG	68	18	26	15	9	-42.3%
13	ModernaTX, Inc.	68	16	16	27	9	+68.8%
14	Hoffmann-La Roche Inc.	67	31	15	15	6	0.0%
15	TRANSLATE BIO, INC.	65	15	22	21	7	-4.5%
16	ANTECIP BIOVENTURES II LLC	64	22	9	24	9	+166.7%
17	Flamel Ireland Limited	63	11	29	17	6	-41.4%
18	Pfizer Inc.	57	17	22	11	7	-50.0%
19	The Board of Trustees of the Leland Stanford Junior University	57	14	21	15	7	-28.6%
20	The Brigham and Women's Hospital, Inc.	55	25	11	14	5	+27.3%
21	Gilead Sciences, Inc.	54	18	8	16	12	+100.0%
22	Chugai Seiyaku Kabushiki Kaisha	53	15	18	14	6	-22.2%
23	ARCUTIS BIOTHERAPEUTICS, INC.	52	15	21	14	2	-33.3%
24	Genentech, Inc.	50	15	17	16	2	-5.9%
25	CORNELL UNIVERSITY	49	14	15	16	4	+6.7%